Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2002 May;86(5):339–343. doi: 10.1136/adc.86.5.339

Hepatitis C-Z: recent advances

D Kelly 1, S Skidmore 1
PMCID: PMC1751087  PMID: 11970925

Full Text

The Full Text of this article is available as a PDF (138.2 KB).

Figure 1 .

Figure 1

Open in a new tab

Proposed management and investigation of hepatitis C in childhood. *High risk patients include: recipients of multiple transfusions/pooled blood products/organ transplants pre-1990, infants of HCV positive mothers (at 12 months). †Anti-HCV by third generation assay; may be positive in infants of HCV positive mothers 9–12 months by passive transfer.

Figure 2 .

Figure 2

Open in a new tab

Investigation and management of viral hepatitis. *Exclude Wilson's disease. †Autoimmune liver disease. ‡α1 antitrypsin deficiency.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal R., Krawczynski K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol. 2000 Jan;15(1):9–20. doi: 10.1046/j.1440-1746.2000.02006.x. [DOI] [PubMed] [Google Scholar]
  2. Alter M. J., Kruszon-Moran D., Nainan O. V., McQuillan G. M., Gao F., Moyer L. A., Kaslow R. A., Margolis H. S. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999 Aug 19;341(8):556–562. doi: 10.1056/NEJM199908193410802. [DOI] [PubMed] [Google Scholar]
  3. Alvarez R. J., Liu N. J., Isaacson G. Pediatric ethmoid mucoceles in cystic fibrosis: long-term follow-up of reported cases. Ear Nose Throat J. 1997 Aug;76(8):538-9, 543-6. [PubMed] [Google Scholar]
  4. Azzari C., Resti M., Moriondo M., Ferrari R., Lionetti P., Vierucci A. Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood. 2000 Sep 15;96(6):2045–2048. [PubMed] [Google Scholar]
  5. Badizadegan K., Jonas M. M., Ott M. J., Nelson S. P., Perez-Atayde A. R. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology. 1998 Nov;28(5):1416–1423. doi: 10.1002/hep.510280534. [DOI] [PubMed] [Google Scholar]
  6. Bellentani S., Pozzato G., Saccoccio G., Crovatto M., Crocè L. S., Mazzoran L., Masutti F., Cristianini G., Tiribelli C. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut. 1999 Jun;44(6):874–880. doi: 10.1136/gut.44.6.874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Casanovas Lax J., Silva García G., Vargas Romero J., Nogales Pérez M. C., Aguayo Maldonado J., Cruz Guerrero G., González Hachero J. Transmisión vertical del virus de la hepatitis C. An Esp Pediatr. 1997 Dec;47(6):627–632. [PubMed] [Google Scholar]
  8. Chen H. L., Chang M. H., Lin H. H., Ni Y. H., Hsu H. Y., Wang J. T., Chen D. S. Antibodies to E2 protein of hepatitis G virus in children: different responses according to age at infection. J Pediatr. 1998 Sep;133(3):382–385. doi: 10.1016/s0022-3476(98)70274-4. [DOI] [PubMed] [Google Scholar]
  9. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  10. Christensson B., Wiebe T., Akesson A., Widell A. Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis. 2000 Mar;30(3):585–586. doi: 10.1086/313709. [DOI] [PubMed] [Google Scholar]
  11. Clayson E. T., Myint K. S., Snitbhan R., Vaughn D. W., Innis B. L., Chan L., Cheung P., Shrestha M. P. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis. 1995 Oct;172(4):927–933. doi: 10.1093/infdis/172.4.927. [DOI] [PubMed] [Google Scholar]
  12. Croxson M., Couper A., Voss L., Groves D., Gunn T. Vertical transmission of hepatitis C virus in New Zealand. N Z Med J. 1997 May 9;110(1043):165–167. [PubMed] [Google Scholar]
  13. Datz C., Cramp M., Haas T., Dietze O., Nitschko H., Froesner G., Muss N., Sandhofer F., Vogel W. The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut. 1999 Apr;44(4):563–567. doi: 10.1136/gut.44.4.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Davis G. L., Esteban-Mur R., Rustgi V., Hoefs J., Gordon S. C., Trepo C., Shiffman M. L., Zeuzem S., Craxi A., Ling M. H. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med. 1998 Nov 19;339(21):1493–1499. doi: 10.1056/NEJM199811193392102. [DOI] [PubMed] [Google Scholar]
  15. Davison S. M., Skidmore S. J., Collingham K. E., Irving W. L., Hubscher S. G., Kelly D. A. Chronic hepatitis in children after liver transplantation: role of hepatitis C virus and hepatitis G virus infections. J Hepatol. 1998 May;28(5):764–770. doi: 10.1016/s0168-8278(98)80225-0. [DOI] [PubMed] [Google Scholar]
  16. Dore G. J., Kaldor J. M., McCaughan G. W. Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ. 1997 Aug 9;315(7104):333–337. doi: 10.1136/bmj.315.7104.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fagan E. A. Acute liver failure of unknown pathogenesis: the hidden agenda. Hepatology. 1994 May;19(5):1307–1312. [PubMed] [Google Scholar]
  18. Fattovich G., Giustina G., Christensen E., Pantalena M., Zagni I., Realdi G., Schalm S. W. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut. 2000 Mar;46(3):420–426. doi: 10.1136/gut.46.3.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Goldberg D., Cameron S., McMenamin J. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Commun Dis Public Health. 1998 Jun;1(2):95–97. [PubMed] [Google Scholar]
  20. Gonçales F. L., Jr, Stucchi R. S., Pavan M. H., Angerami R. N., Gonçales N. S. Hepatitis C virus in monozygotic twins. Rev Inst Med Trop Sao Paulo. 2000 May-Jun;42(3):163–165. doi: 10.1590/s0036-46652000000300010. [DOI] [PubMed] [Google Scholar]
  21. Gunasekaran T. S., Holterman M., Siegfried M., VandenBranden S. Clinical quiz. Necrotizing fascitis. J Pediatr Gastroenterol Nutr. 2000 Aug;31(2):203–207. doi: 10.1097/00005176-200008000-00025. [DOI] [PubMed] [Google Scholar]
  22. Handa A., Jubran R. F., Dickstein B., Boylan A., Luban N. L., Young N. S., Brown K. E. GB virus C/Hepatitis G virus infection is frequent in American children and young adults. Clin Infect Dis. 2000 Mar;30(3):569–571. doi: 10.1086/313702. [DOI] [PubMed] [Google Scholar]
  23. Hardikar W., Moaven L. D., Bowden D. S., Locarnini S. A., Smith A. L. Hepatitis G: viroprevalence and seroconversion in a high-risk group of children. J Viral Hepat. 1999 Jul;6(4):337–341. doi: 10.1046/j.1365-2893.1999.00172.x. [DOI] [PubMed] [Google Scholar]
  24. Hartley B. E., Lund V. J. Endoscopic drainage of pediatric paranasal sinus mucoceles. Int J Pediatr Otorhinolaryngol. 1999 Oct 25;50(2):109–111. doi: 10.1016/s0165-5876(99)00220-7. [DOI] [PubMed] [Google Scholar]
  25. Hsieh S. Y., Wu Y. H., Ho Y. P., Tsao K. C., Yeh C. T., Liaw Y. F. High prevalence of TT virus infection in healthy children and adults and in patients with liver disease in Taiwan. J Clin Microbiol. 1999 Jun;37(6):1829–1831. doi: 10.1128/jcm.37.6.1829-1831.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hussaini S. H., Skidmore S. J., Richardson P., Sherratt L. M., Cooper B. T., O'Grady J. G. Severe hepatitis E infection during pregnancy. J Viral Hepat. 1997 Jan;4(1):51–54. doi: 10.1046/j.1365-2893.1997.00123.x. [DOI] [PubMed] [Google Scholar]
  27. Iorio R., Pensati P., Botta S., Vajro P., Sepe A., Donetto S., Vecchione R., Artini M., Levrero M., Vegnente A. Chronic cryptogenic hepatitis in childhood is unrelated to hepatitis G virus. Pediatr Infect Dis J. 1999 Apr;18(4):347–351. doi: 10.1097/00006454-199904000-00008. [DOI] [PubMed] [Google Scholar]
  28. Iorio R., Pensati P., Porzio S., Fariello I., Guida S., Vegnente A. Lymphoblastoid interferon alfa treatment in chronic hepatitis C. Arch Dis Child. 1996 Feb;74(2):152–156. doi: 10.1136/adc.74.2.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Irish D. N., Blake C., Christophers J., Craske J. E., Burnapp L., Abbs I. C., MacMahon E. M., Muir P., Banatvala J. E., Simmonds P. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening. J Med Virol. 1999 Oct;59(2):135–140. [PubMed] [Google Scholar]
  30. Iriyama M., Kimura H., Nishikawa K., Yoshioka K., Wakita T., Nishimura N., Shibata M., Ozaki T., Morishima T. The prevalence of TT virus (TTV) infection and its relationship to hepatitis in children. Med Microbiol Immunol. 1999 Nov;188(2):83–89. doi: 10.1007/s004300050109. [DOI] [PubMed] [Google Scholar]
  31. Jaiswal S. P., Jain A. K., Naik G., Soni N., Chitnis D. S. Viral hepatitis during pregnancy. Int J Gynaecol Obstet. 2001 Feb;72(2):103–108. doi: 10.1016/s0020-7292(00)00264-2. [DOI] [PubMed] [Google Scholar]
  32. Kao J. H., Liu C. J., Chen P. J., Chen W., Hsiang S. C., Lai M. Y., Chen D. S. Interspousal transmission of GB virus-C/hepatitis G virus: a comparison with hepatitis C virus. J Med Virol. 1997 Dec;53(4):348–353. [PubMed] [Google Scholar]
  33. Khuroo M. S., Teli M. R., Skidmore S., Sofi M. A., Khuroo M. I. Incidence and severity of viral hepatitis in pregnancy. Am J Med. 1981 Feb;70(2):252–255. doi: 10.1016/0002-9343(81)90758-0. [DOI] [PubMed] [Google Scholar]
  34. Linnen J., Wages J., Jr, Zhang-Keck Z. Y., Fry K. E., Krawczynski K. Z., Alter H., Koonin E., Gallagher M., Alter M., Hadziyannis S. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996 Jan 26;271(5248):505–508. doi: 10.1126/science.271.5248.505. [DOI] [PubMed] [Google Scholar]
  35. Maeda M., Hamada H., Tsuda A., Kaneko K., Fukunaga Y. High rate of TTV infection in multitransfused patients with pediatric malignancy and hematological disorders. Am J Hematol. 2000 Sep;65(1):41–44. doi: 10.1002/1096-8652(200009)65:1<41::aid-ajh7>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  36. Mast E. E., Alter M. J., Holland P. V., Purcell R. H. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology. 1998 Mar;27(3):857–861. doi: 10.1002/hep.510270331. [DOI] [PubMed] [Google Scholar]
  37. McHutchison J. G., Person J. L., Govindarajan S., Valinluck B., Gore T., Lee S. R., Nelles M., Polito A., Chien D., DiNello R. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology. 1992 Jan;15(1):19–25. doi: 10.1002/hep.1840150105. [DOI] [PubMed] [Google Scholar]
  38. Meisel H., Reip A., Faltus B., Lu M., Porst H., Wiese M., Roggendorf M., Krüger D. H. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet. 1995 May 13;345(8959):1209–1211. doi: 10.1016/s0140-6736(95)91992-9. [DOI] [PubMed] [Google Scholar]
  39. Mphahlele M. J., Aspinall S., Spooner R., Carman W. F. Age related prevalence of hepatitis G virus in South Africans. J Clin Pathol. 1999 Oct;52(10):752–757. doi: 10.1136/jcp.52.10.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Muñoz S. J., Alter H. J., Nakatsuji Y., Shih J. W., Reddy R. K., Jeffers L., Schiff E. R., Reid A. E., Marrone A., Rothstein K. The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology. Blood. 1999 Aug 15;94(4):1460–1464. [PubMed] [Google Scholar]
  41. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 1997 Dec 8;241(1):92–97. doi: 10.1006/bbrc.1997.7765. [DOI] [PubMed] [Google Scholar]
  42. Orland J. R., Wright T. L., Cooper S. Acute hepatitis C. Hepatology. 2001 Feb;33(2):321–327. doi: 10.1053/jhep.2001.22112. [DOI] [PubMed] [Google Scholar]
  43. Parvaz P., Guichard E., Chevallier P., Ritter J., Trepo C., Sepetjan M. Hepatitis C: description of a highly sensitive method for clinical detection of viral RNA. J Virol Methods. 1994 Apr;47(1-2):83–94. doi: 10.1016/0166-0934(94)90068-x. [DOI] [PubMed] [Google Scholar]
  44. Peterson J., Green G., Iida K., Caldwell B., Kerrison P., Bernich S., Aoyagi K., Lee S. R. Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection. Vox Sang. 2000;78(2):80–85. doi: 10.1159/000031155. [DOI] [PubMed] [Google Scholar]
  45. Poynard T., Leroy V., Cohard M., Thevenot T., Mathurin P., Opolon P., Zarski J. P. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology. 1996 Oct;24(4):778–789. doi: 10.1002/hep.510240405. [DOI] [PubMed] [Google Scholar]
  46. Reddy K. R., Wright T. L., Pockros P. J., Shiffman M., Everson G., Reindollar R., Fried M. W., Purdum P. P., 3rd, Jensen D., Smith C. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology. 2001 Feb;33(2):433–438. doi: 10.1053/jhep.2001.21747. [DOI] [PubMed] [Google Scholar]
  47. Resti M., Azzari C., Mannelli F., Moriondo M., Novembre E., de Martino M., Vierucci A. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ. 1998 Aug 15;317(7156):437–441. doi: 10.1136/bmj.317.7156.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Resti M., Bortolotti F., Azzari C., Giacchino R., Zancan L., Gussetti N., Vierucci A. Transmission of hepatitis C virus from infected mother to offspring during subsequent pregnancies. J Pediatr Gastroenterol Nutr. 2000 May;30(5):491–493. doi: 10.1097/00005176-200005000-00006. [DOI] [PubMed] [Google Scholar]
  49. Rizzetto M., Canese M. G., Aricò S., Crivelli O., Trepo C., Bonino F., Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977 Dec;18(12):997–1003. doi: 10.1136/gut.18.12.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Roberts E. A., King S. M., Fearon M., McGee N. Hepatitis C in children after transfusion: assessment by look-back studies. Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):195–197. [PubMed] [Google Scholar]
  51. Robertson D. M., Henderson J. W. Unilateral proptosis secondary to orbital mucocele in infancy. Am J Ophthalmol. 1969 Nov;68(5):845–847. doi: 10.1016/0002-9394(69)94578-4. [DOI] [PubMed] [Google Scholar]
  52. Roudot-Thoraval F., Pawlotsky J. M., Thiers V., Deforges L., Girollet P. P., Guillot F., Huraux C., Aumont P., Brechot C., Dhumeaux D. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology. 1993 May;17(5):772–777. [PubMed] [Google Scholar]
  53. Ruiz-Extremera A., Salmerón J., Torres C., De Rueda P. M., Giménez F., Robles C., Miranda M. T. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breast-feeding in transmission. Pediatr Infect Dis J. 2000 Jun;19(6):511–516. doi: 10.1097/00006454-200006000-00004. [DOI] [PubMed] [Google Scholar]
  54. Scallan M. F., Clutterbuck D., Jarvis L. M., Scott G. R., Simmonds P. Sexual transmission of GB virus C/hepatitis G virus. J Med Virol. 1998 Jul;55(3):203–208. doi: 10.1002/(sici)1096-9071(199807)55:3<203::aid-jmv4>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  55. Schneider A., Habermehl P., Gerner P., Lausch E., Ballauff A., Wirth S. Alpha-interferon treatment in HBeAg positive children with chronic hepatitis B and associated hepatitis D. Klin Padiatr. 1998 Sep-Oct;210(5):363–365. doi: 10.1055/s-2008-1043904. [DOI] [PubMed] [Google Scholar]
  56. Seemayer C. A., Viazov S., Philipp T., Roggendorf M. Detection of GBV-C/HGV RNA in saliva and serum, but not in urine of infected patients. Infection. 1998 Jan-Feb;26(1):39–41. doi: 10.1007/BF02768751. [DOI] [PubMed] [Google Scholar]
  57. Sharma G. D., Doershuk C. F., Stern R. C. Erosion of the wall of the frontal sinus caused by mucopyocele in cystic fibrosis. J Pediatr. 1994 May;124(5 Pt 1):745–747. doi: 10.1016/s0022-3476(05)81368-x. [DOI] [PubMed] [Google Scholar]
  58. Shattock A. G., Irwin F. M., Morgan B. M., Hillary I. B., Kelly M. G., Fielding J. F., Kelly D. A., Weir D. G. Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) 1985 May 11;290(6479):1377–1380. doi: 10.1136/bmj.290.6479.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Simmonds P., Holmes E. C., Cha T. A., Chan S. W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993 Nov;74(Pt 11):2391–2399. doi: 10.1099/0022-1317-74-11-2391. [DOI] [PubMed] [Google Scholar]
  60. Simons J. N., Leary T. P., Dawson G. J., Pilot-Matias T. J., Muerhoff A. S., Schlauder G. G., Desai S. M., Mushahwar I. K. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1995 Jun;1(6):564–569. doi: 10.1038/nm0695-564. [DOI] [PubMed] [Google Scholar]
  61. Skidmore S. J., Collingham K. E., Drake S. M. Brief report: sexual transmission of hepatitis C. J Med Virol. 1994 Mar;42(3):247–248. doi: 10.1002/jmv.1890420308. [DOI] [PubMed] [Google Scholar]
  62. Skidmore S. J., Collingham K. E., Harrison P., Neilson J. R., Pillay D., Milligan D. W. High prevalence of hepatitis G virus in bone marrow transplant recipients and patients treated for acute leukemia. Blood. 1997 May 15;89(10):3853–3856. [PubMed] [Google Scholar]
  63. Skidmore S. J., Pasi K. J., Mawson S. J., Williams M. D., Hill F. G. Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis. J Med Virol. 1990 Jan;30(1):50–52. doi: 10.1002/jmv.1890300111. [DOI] [PubMed] [Google Scholar]
  64. Skidmore S. J., Sherratt L. M. Hepatitis E infection in the UK. J Viral Hepat. 1996 Mar;3(2):103–105. doi: 10.1111/j.1365-2893.1996.tb00088.x. [DOI] [PubMed] [Google Scholar]
  65. Skidmore S. J., Yarbough P. O., Gabor K. A., Reyes G. R. Hepatitis E virus: the cause of a waterbourne hepatitis outbreak. J Med Virol. 1992 May;37(1):58–60. doi: 10.1002/jmv.1890370110. [DOI] [PubMed] [Google Scholar]
  66. Sugiyama K., Goto K., Ando T., Mizutani F., Terabe K., Yokoyama T. Highly diverse TTV population in infants and their mothers. Virus Res. 2001 Mar;73(2):183–188. doi: 10.1016/s0168-1702(00)00242-2. [DOI] [PubMed] [Google Scholar]
  67. Tacke M., Kiyosawa K., Stark K., Schlueter V., Ofenloch-Haehnle B., Hess G., Engel A. M. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet. 1997 Feb 1;349(9048):318–320. doi: 10.1016/S0140-6736(96)06461-6. [DOI] [PubMed] [Google Scholar]
  68. Thomas S. L., Newell M. L., Peckham C. S., Ades A. E., Hall A. J. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol. 1998 Feb;27(1):108–117. doi: 10.1093/ije/27.1.108. [DOI] [PubMed] [Google Scholar]
  69. Thomé D. C., Voegels R. L., Cataldo de la Cortina R. A., Butugan O. Bilateral ethmoidal mucocele in cystic fibrosis: report of a case. Int J Pediatr Otorhinolaryngol. 2000 Sep 29;55(2):143–148. doi: 10.1016/s0165-5876(00)00375-x. [DOI] [PubMed] [Google Scholar]
  70. Tovo P. A., Pembrey L. J., Newell M. L. Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. J Infect Dis. 2000 Feb;181(2):419–424. doi: 10.1086/315264. [DOI] [PubMed] [Google Scholar]
  71. Vogt M., Lang T., Frösner G., Klingler C., Sendl A. F., Zeller A., Wiebecke B., Langer B., Meisner H., Hess J. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999 Sep 16;341(12):866–870. doi: 10.1056/NEJM199909163411202. [DOI] [PubMed] [Google Scholar]
  72. Wejstål R., Månson A. S., Widell A., Norkrans G. Perinatal transmission of hepatitis G virus (GB virus type C) and hepatitis C virus infections--a comparison. Clin Infect Dis. 1999 Apr;28(4):816–821. doi: 10.1086/515187. [DOI] [PubMed] [Google Scholar]
  73. Wong D. C., Purcell R. H., Sreenivasan M. A., Prasad S. R., Pavri K. M. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet. 1980 Oct 25;2(8200):876–879. doi: 10.1016/s0140-6736(80)92045-0. [DOI] [PubMed] [Google Scholar]
  74. Zanetti A. R., Tanzi E., Romanó L., Principi N., Zuin G., Minola E., Zapparoli B., Palmieri M., Marini A., Ghisotti D. Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical/Perinatal Hepatitis Viruses Transmission. J Med Virol. 1998 Feb;54(2):107–112. doi: 10.1002/(sici)1096-9071(199802)54:2<107::aid-jmv7>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  75. Zuckerman J., Clewley G., Griffiths P., Cockcroft A. Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet. 1994 Jun 25;343(8913):1618–1620. doi: 10.1016/s0140-6736(94)93064-3. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES